In 2009, Dr. Townsend will move from the University of Tennessee to serve as Director of PET Development at the National University of Singapore and will work with A*STAR, Singapore's Agency for Science Technology and Research.

Dr. Ronald Nutt oversaw CTI and CTI PET Systems acquisition by Siemens, serving for a time as Chief Scientific Advisor for Siemens Molecular Imaging, a division of Siemens Medical Solutions.

Presently, Dr. Nutt serves on the board of Advanced Biomarker Technologies, a company he founded which specializes in improving molecular imaging by developing a small cyclotron design with associated radiochemistry production.

Dr. Nutt was unavailable for comment at the time of this writing.

Reed McManigle, formerly with the Office of Technology Management at Pitt, who provided deposition testimony in the case, said he was "not able to comment on ongoing litigation" and would not confirm whether Pitt was planning further appeal. McManigle now serves as the Manager of Business Development and Licensing at Carnegie Mellon University.

The University of Pittsburgh's Office of Technology Management replied "no comment" when asked if they planned to pursue the case further. However, the time for Pitt to seek a writ of certiorari from the U.S. Supreme Court has expired.